The mRNA COVID-19 vaccines, which have been crucial in saving lives, utilized specific lipid nanoparticles to deliver ... a signaling molecule crucial for tissue repair. This research marks ...
Company is applying its T cell-selective lipid nanoparticle ... space for T cell-specific therapies.” Business Highlights Delivering siRNA with a T cell-selective LNP could enable selective modulation ...
The convergence of AI and drug delivery is opening new frontiers in precision medicine. AI-powered predictive modeling is ...
Company is applying its T cell-selective lipid nanoparticle to develop siRNA therapeutics for ... creating a new application space for T cell-specific therapies." Business Highlights Applying T ...
Novo Nordisk has signed a deal with AI-driven protein design company Gensaic to develop tissue-targeted therapies ... NanoVation’s long-circulating lipid nanoparticle (lcLNP) technology for ...
The company is developing a new modality of therapeutics leveraging its T cell-selective cell-targeted lipid nanoparticle (ctLNP) to deliver siRNA in vivo, enabling modulation of T cell activity that ...
Immunotherapy has emerged as one of the major options for cancer treatment in the past decade. With the successful application of immune checkpoint inhibitors and the introduction of immune regulatory ...
2d
Enhanced Regenerative Potential: Stem cell-derived exosomes accelerate wound healing and tissue regeneration. Market Research Future Market Research Future +1 855-661-4441 email us here Visit us on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback